`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`
`GARDNER DENVER, INC.
`Petitioner,
`
`v.
`
`UTEX INDUSTRIES, INC.
`Patent Owner
`____________________________________________
`
`Case IPR2020-00333
`Patent No. 10,428,949
`____________________________________________
`
`JOINT MOTION TO SEAL PURSUANT TO PROTECTIVE ORDER
`
`
`Active 51848945.1
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.14 and 42.54 and the Protective Order
`
`concurrently filed in this proceeding on July 9, 2020 (“Protective Order”) (Paper 8,
`
`Ex. A), Patent Owner, Utex Industries, Inc. (“Utex”), and Petitioner, Gardner
`
`Denver, Inc. (“Gardner Denver”) respectfully submit this Motion to Seal.
`
`I.
`
`DOCUMENTS TO BE SEALED
`
`
`
`
`
`A.
`
`Preliminary Response
`
`Patent Owner’s Preliminary Response contains confidential information of
`
`Petitioner related to Ex. 2001, which has been designated as “Protective Order
`
`Material” pursuant to the Protective Order. Specifically, Patent Owner’s Preliminary
`
`Response discusses at page 58 material from paragraph 194 of Vinod Sharma’s
`
`Declaration (Ex. 2001 to the Patent Owner’s Preliminary Response) which is
`
`confidential information of Gardner Denver, as explained below. Paper No. 7 at 58.
`
`B.
`
`Ex. 2001
`
`Mr. Sharma’s Declaration contains discussions of the confidential material
`
`regarding Gardner Denver’s research and development efforts which has been
`
`designated as Protective Order Material by Petitioner. Specifically, in paragraph
`
`194 of his declaration, Mr. Sharma indicates that he has reviewed certain documents
`
`from Gardner Denver and summarizes information that he asserts the documents
`
`show. Ex. 2001 ¶ 194. This information relates to Gardner Denver’s research and
`
`development efforts prior to the issuance of a Utex patent to which the patent at issue
`
`
`
`1
`
`
`
`in this proceeding claims priority. See id. That patent is also asserted against
`
`Gardner Denver in a co-pending litigation between Utex and Gardner Denver. The
`
`documents and information regarding Gardner Denver’s research and development
`
`efforts have been designated as “Highly Confidential-Attorneys’ Eyes Only”
`
`pursuant to the Protective Order in that litigation because they comprise details
`
`regarding Petitioner’s confidential research and development for its packing
`
`products that Petitioner deems especially sensitive. As such, Ex. 2001 contains
`
`designated Protective Order Material that should be sealed pursuant to the Protective
`
`Order. Pursuant to Section 5(A)(ii) of the Protective Order, Utex and Gardner
`
`Denver will confer regarding the scope of redactions necessary to seal this Protective
`
`Order information, and will file public redacted non-confidential versions of the
`
`Preliminary Response and Ex. 2001.
`
`II. GOOD CAUSE FOR SEALING THE IDENTIFIED DOCUMENTS
`
`
`
`When enacting inter partes reviews (“IPRs”), Congress directed the Patent
`
`Trial and Appeal Board (“the Board”) to “provid[e] for protective orders governing
`
`the exchange and submission of confidential information.” 35 U.S.C. § 316(a)(7).
`
`Thus, “[t]he Board may, for good cause, issue an order to protect a party or person
`
`from disclosing confidential information . . .” 37 C.F.R. § 42.54(a). In Argentum
`
`Pharmaceuticals LLC v. Alcon Research, Ltd., IPR2017-01053, Paper 27 (Jan. 19,
`
`2018), the Board set forth the standard for sealing confidential information:
`
`
`
`2
`
`
`
`[A] movant to seal must demonstrate adequately that (1) the
`information sought to be sealed is truly confidential, (2) a concrete
`harm would result upon public disclosure, (3) there exists a genuine
`need to rely in the trial on the specific information sought to be sealed,
`and (4) on balance, an interest in maintaining confidentiality outweighs
`the strong public interest in having an open record.
`
`Id. at 3. While there is a presumption in favor of public disclosure, and the burden
`
`is on the movant to seal, application of the foregoing factors should be tempered by
`
`reasonableness, which is the touchstone of good cause. Overly harsh or stringent
`
`application of the “good cause” requirement would be contrary to Congress’ intent
`
`that IPRs be conducted in a “timely, fair, and efficient manner” as an alternative to
`
`expensive court litigation of patent validity. Office Patent Trial Practice Guide, 77
`
`Fed. Reg. 48,756, 48,756 (Aug. 12, 2012).
`
`
`
`As explained below, the Argentum factors confirm that the information the
`
`Parties seek to protect from public disclosure should indeed be sealed in this
`
`proceeding.
`
`
`
`
`
`A. Confidential
`
`The information regarding Gardner Denver’s confidential research and
`
`development efforts that appears in Exhibit 2001 and the Preliminary Response is
`
`truly confidential. That information is not publicly available. More specifically,
`
`Gardner Denver asserts that Exhibit 2001 has discussion of Gardner Denver’s
`
`
`
`3
`
`
`
`confidential research and development efforts prior to the issuance of the patent-in-
`
`suit in the co-pending litigation between Gardner Denver and Utex. Gardner Denver
`
`further asserts that, if published, this information could adversely affect Gardner
`
`Denver. For example, Gardner Denver asserts that Mr. Sharma’s description of its
`
`confidential research and development efforts both discloses sensitive information
`
`about those efforts and is incomplete. Gardner Denver asserts that in order for
`
`Gardner Denver to provide the full context, it would have to disclose additional
`
`confidential research and development information. Gardner Denver further asserts
`
`that disclosure of the sensitive information that is already in Mr. Sharma’s
`
`declaration would harm its ability to compete in the marketplace. While Utex does
`
`not agree that Mr. Sharma’s description of such information is incomplete or that
`
`Gardner Denver would have to disclose additional confidential research and
`
`development information in response to Mr. Sharma, Utex consents to the
`
`information being treated as confidential information for the purposes of this
`
`proceeding.
`
`
`
`
`
`B. Concrete Harm from Public Disclosure
`
`Gardner Denver believes that public disclosure of the information in Exhibit
`
`2001 and relied upon in the Preliminary Response would cause concrete harm to the
`
`Gardner Denver. As discussed above, Gardner Denver asserts that Mr. Sharma’s
`
`discussion of its confidential research and development efforts is incomplete, and
`
`
`
`4
`
`
`
`public disclosure of the information without additional context could harm Gardner
`
`Denver’s reputation in the marketplace. However, Gardner Denver asserts that in
`
`order to provide full context, Gardner Denver would need to publicly disclose
`
`additional confidential research and development information. Gardner Denver
`
`further asserts that a competitor or others could use such information to gain an
`
`unfair advantage in the packing market. Again, as discussed above, while Utex does
`
`not agree that Mr. Sharma’s description of the information is incomplete or that
`
`Gardner Denver would have to disclose additional confidential research and
`
`development information in response to Mr. Sharma, Utex consents to the
`
`information being treated as confidential information for the purposes of this
`
`proceeding.
`
`
`
`
`
`C. Genuine Need to Rely Upon
`
`Utex relies on Ex. 2001, among other evidence, to support its Preliminary
`
`Response. The information relied upon is not available from any non-confidential
`
`sources and Utex asserts it is highly relevant to its arguments that the challenged
`
`claims are patentable. As a result, Utex has a genuine need to rely on this Protective
`
`Order Material information in the above-listed exhibit.
`
`
`
`
`
`D.
`
`Balancing
`
`The parties’ need for confidentiality outweighs the public’s interest in having
`
`a fully open record. Utex relies on the sensitive research and development
`
`
`
`5
`
`
`
`information, in addition to other evidence, to support its Preliminary Response in
`
`order to fully defend itself in this proceeding. Further, Utex and Petitioner will
`
`submit redactions tailored to remove the confidential information while revealing to
`
`the public as much as possible, striking an appropriate balance of the public’s
`
`qualified interest in having an open record, on the one hand, and the interest in
`
`maintaining the confidential information in accordance with the Protective Order on
`
`the other.
`
`III. CERTIFICATION OF CONFERENCE WITH OPPOSING PARTY
`PURSUANT TO 37 C.F.R. § 42.54(a)
`As set forth in the Joint Motion to Enter Jointly Proposed Protective Order
`
`
`
`(Paper 8), Counsel for Utex and Petitioner conferred regarding the proposed
`
`Protective Order submitted to the Board and agree that the proposed Protective Order
`
`(Paper 8, Ex. A) calls for and authorizes this sealing request. Since the documents
`
`referenced herein were designated Protective Order Material, the information that is
`
`the subject of this motion should be sealed.
`
`IV. NON-CONFIDENTIAL
`DOCUMENTS
`
`VERSIONS
`
`OF
`
`CONFIDENTIAL
`
`
`
`
`Pursuant to Section 5(A)(ii) of the Protective Order, Utex will file public
`
`record versions of the documents filed under seal that exclude or redact any
`
`confidential information. The redactions will be tailored to protect only that
`
`confidential information as outlined in the Protective Order.
`
`
`
`6
`
`
`
`V. CONCLUSION
`
`The Parties jointly respectfully request that the Board grant this Motion to
`
`Seal.
`
`Date: July 9, 2020
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Helena D. Kiepura/
`Helena D. Kiepura (Reg. No. 64,441)
`helena.kiepura@kirkland.com
`KIRKLAND & ELLIS LLP
`1301 Pennsylvania Ave., N.W.
`Washington, D.C. 20004
`(202) 389-5000
`
`Benjamin J. Behrendt (Reg. No.
`71,417)
`benjamin.behrendt@kirkland.com
`KIRKLAND & ELLIS LLP
`1301 Pennsylvania Ave., N.W.
`Washington, D.C. 20004
`(202) 389-5000
`
`Attorneys for Gardner Denver, Inc.
`
`
`/Paul Morico/
`Paul Morico
`Reg. No. 35,960
`Paul.morico@bakerbotts.com
`Baker Botts LLP
`910 Louisiana Street
`Houston, Texas 77002
`Telephone: 713.229.1732
`
`Natalie Alfaro Gonzales
`Reg. No. 68, 554
`Natalie.gonzales@bakerbotts.com
`Baker Botts LLP
`7
`
`
`
`910 Louisiana Street
`Houston, Texas 77002
`Telephone: 713.229.1318
`
`Attorneys for Utex Industries, Inc.
`
`8
`
`
`
`
`
`
`
`